Fresenius Medical Care AG KGaA EBITDA 2010-2024 | FMS
Fresenius Medical Care AG KGaA annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Fresenius Medical Care AG KGaA EBITDA for the quarter ending September 30, 2024 was $0.931B, a 10.19% increase year-over-year.
- Fresenius Medical Care AG KGaA EBITDA for the twelve months ending September 30, 2024 was $3.538B, a 3.63% increase year-over-year.
- Fresenius Medical Care AG KGaA 2023 annual EBITDA was $3.378B, a 4.29% decline from 2022.
- Fresenius Medical Care AG KGaA 2022 annual EBITDA was $3.53B, a 14.17% decline from 2021.
- Fresenius Medical Care AG KGaA 2021 annual EBITDA was $4.112B, a 11.98% decline from 2020.
| Fresenius Medical Care AG KGaA Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $3,378 |
| 2022 | $3,530 |
| 2021 | $4,112 |
| 2020 | $4,672 |
| 2019 | $4,326 |
| 2018 | $4,444 |
| 2017 | $3,502 |
| 2016 | $3,413 |
| 2015 | $3,044 |
| 2014 | $2,954 |
| 2013 | $2,878 |
| 2012 | $2,768 |
| 2011 | $2,601 |
| 2010 | $2,427 |
| 2009 | $2,213 |
| Fresenius Medical Care AG KGaA Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $931 |
| 2024-06-30 | $870 |
| 2024-03-31 | $823 |
| 2023-12-31 | $913 |
| 2023-09-30 | $845 |
| 2023-06-30 | $870 |
| 2023-03-31 | $750 |
| 2022-12-31 | $949 |
| 2022-09-30 | $933 |
| 2022-06-30 | $788 |
| 2022-03-31 | $860 |
| 2021-12-31 | $1,035 |
| 2021-09-30 | $1,050 |
| 2021-06-30 | $987 |
| 2021-03-31 | $1,040 |
| 2020-12-31 | $1,192 |
| 2020-09-30 | $1,253 |
| 2020-06-30 | $1,173 |
| 2020-03-31 | $1,054 |
| 2019-12-31 | $1,180 |
| 2019-09-30 | $1,108 |
| 2019-06-30 | $1,017 |
| 2019-03-31 | $1,021 |
| 2018-12-31 | $929 |
| 2018-09-30 | $810 |
| 2018-06-30 | $1,880 |
| 2018-03-31 | $826 |
| 2017-12-31 | $800 |
| 2017-09-30 | $952 |
| 2017-06-30 | $853 |
| 2017-03-31 | $896 |
| 2016-12-31 | $990 |
| 2016-09-30 | $867 |
| 2016-06-30 | $835 |
| 2016-03-31 | $722 |
| 2015-12-31 | $843 |
| 2015-09-30 | $793 |
| 2015-06-30 | $728 |
| 2015-03-31 | $680 |
| 2014-12-31 | $849 |
| 2014-09-30 | $767 |
| 2014-06-30 | $725 |
| 2014-03-31 | $612 |
| 2013-12-31 | $828 |
| 2013-09-30 | $716 |
| 2013-06-30 | $691 |
| 2013-03-31 | $644 |
| 2012-12-31 | $711 |
| 2012-09-30 | $714 |
| 2012-06-30 | $711 |
| 2012-03-31 | $632 |
| 2011-12-31 | $721 |
| 2011-09-30 | $669 |
| 2011-06-30 | $637 |
| 2011-03-31 | $574 |
| 2010-12-31 | $676 |
| 2010-09-30 | $617 |
| 2010-06-30 | $586 |
| 2010-03-31 | $548 |
| 2009-12-31 | $614 |
| 2009-09-30 | $570 |
| 2009-06-30 | $528 |
| 2009-03-31 | $502 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $13.902B | $21.053B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $200.813B | 24.50 |
| Intuitive Surgical (ISRG) | United States | $194.018B | 101.44 |
| Edwards Lifesciences (EW) | United States | $43.628B | 27.70 |
| Alcon (ALC) | Switzerland | $42.291B | 28.30 |
| IQVIA Holdings (IQV) | United States | $36.367B | 20.04 |
| IDEXX Laboratories (IDXX) | United States | $35.798B | 42.16 |
| DexCom (DXCM) | United States | $30.830B | 46.43 |
| Waters (WAT) | United States | $22.743B | 33.63 |
| STERIS (STE) | Ireland | $21.361B | 24.59 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.498B | 0.00 |
| Hologic (HOLX) | United States | $17.041B | 18.40 |
| Sysmex ADR (SSMXY) | Japan | $12.298B | 38.57 |
| Globus Medical (GMED) | United States | $11.262B | 28.52 |
| Penumbra (PEN) | United States | $9.682B | 94.83 |
| Masimo (MASI) | United States | $9.374B | 45.36 |
| Teleflex (TFX) | United States | $8.514B | 13.58 |
| Glaukos (GKOS) | United States | $7.737B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.687B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.672B | 26.48 |
| Veracyte (VCYT) | United States | $3.441B | 103.26 |
| Inari Medical (NARI) | United States | $3.299B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.830B | 16.33 |
| Nihon Kohden (NHNKY) | Japan | $2.541B | 19.30 |
| Tandem Diabetes Care (TNDM) | United States | $2.253B | 0.00 |
| TransMedics (TMDX) | United States | $2.205B | 69.90 |
| Elekta AB (EKTAY) | Sweden | $2.177B | 19.57 |
| Integra LifeSciences Holdings (IART) | United States | $1.870B | 9.77 |
| RxSight (RXST) | United States | $1.447B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.376B | 0.00 |
| Artivion (AORT) | United States | $1.237B | 81.94 |
| OPKO Health (OPK) | United States | $1.099B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.054B | 0.00 |
| Paragon 28 (FNA) | United States | $0.856B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.847B | 14.41 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.691B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.691B | 16.28 |
| IRadimed (IRMD) | United States | $0.690B | 37.28 |
| AxoGen (AXGN) | United States | $0.634B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.595B | 35.04 |
| SiBone (SIBN) | United States | $0.571B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.560B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.475B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.452B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.435B | 23.55 |
| Delcath Systems (DCTH) | United States | $0.377B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.373B | 0.00 |
| NeuroPace (NPCE) | United States | $0.326B | 0.00 |
| CVRx (CVRX) | United States | $0.325B | 0.00 |
| Inogen (INGN) | United States | $0.221B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.202B | 0.00 |
| Accuray (ARAY) | United States | $0.193B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.189B | 0.00 |
| Nevro (NVRO) | United States | $0.158B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.145B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.139B | 14.90 |
| Spectral Diagnostics (EDTXF) | Canada | $0.104B | 0.00 |
| LENSAR (LNSR) | United States | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| InspireMD (NSPR) | Israel | $0.081B | 0.00 |
| 908 Devices (MASS) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.065B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.050B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.042B | 0.00 |
| Spectral AI (MDAI) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.035B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.031B | 0.00 |
| NexGel (NXGL) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.010B | 0.00 | |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |